Danaher | DHR - أصول متداولة





أصول متداولة تغيير تاريخ
Abbott USD 25.51B 488M 2026-03
Agilent USD 4.76B 148M 2026-03
Align Technology USD 2.66B 7.62M 2026-06
Becton, Dickinson and Co. USD 8.14B 127M 2026-06
Bio Techne USD 688.05M 50.62M 2026-03
Bio-Rad Laboratories USD 3.02B 78.4M 2026-06
Boston Scientific USD 7.97B 712M 2026-06
Bruker USD 2.22B 121.4M 2026-06
Charles River Laboratories USD 1.53B 40.3M 2026-06
Danaher USD 13.38B 554M 2026-06
Dentsply International USD 1.93B 83M 2026-06
Edwards Lifesciences USD 6.82B 590.2M 2026-06
ESCO Technologies USD 755.51M 28.72M 2026-06
Fortive USD 1.6B 49.9M 2026-06
Henry Schein USD 4.6B 104M 2026-06
Illumina USD 2.83B 96M 2026-06
Intuitive Surgical USD 12.33B 807.5M 2026-06
IQVIA Holdings USD 6.23B 6M 2026-06
Keysight Technologies USD 5.29B 244M 2026-06
Laboratory Of America USD 3.81B 743.9M 2026-06
Medtronic USD 24.07B 75M 2025-12
Mettler Toledo International USD 1.35B 15.48M 2026-06
Myriad Genetics USD 289M 23.8M 2026-06
OraSure Technologies USD 222.94M 17.84M 2026-06
Quest Diagnostics USD 2.84B 278M 2026-06
Quidel USD 1.38B 400K 2026-06
Repligen USD 1.2B 39.19M 2026-06
Revvity USD 2.3B 169.4M 2026-06
Roper Industries USD 1.92B 6.4M 2026-06
Stryker USD 14.42B 1.08B 2026-06
Thermo Fisher Scientific USD 23.36B 1.05B 2026-06
Waters USD 3.9B 186M 2026-06
Zimmer Biomet Holdings USD 5.1B 134.2M 2026-06